Please publish the series. Would be genuinely novel, supposedly with an enormous n. Would be nice to know which patients were treated, by what modality. Perhaps there is learning here, perhaps exaggeration. I believe the focal community would welcome the insight.
If I had a nickel for every time a friend asked me about prostate focal therapy, I’d be rich.View quoted post on X
I’ve personally managed 20–30 intraprostatic failures after focal therapy. One patient ended up with a permanent Foley after salvage RT. Nearly all required medical castration, which many likely could have avoided with definitive therapy upfront. The downstream consequences are real.
Our group ultimately decided not to offer focal therapy outside of very niche scenarios (for example select reirradiation not ideal for partial or full gland SBRT). If I were a patient, I might assume focal therapy is better than standard options too. The marketing is that good. #OncTwitter